跳至主要内容
临床试验/CTIS2024-515986-33-00
CTIS2024-515986-33-00招募中1 期

Dose escalating study to evaluate pharmacokinetics, efficacy and safety of apotransferrin in atransferrinemia patients - MD2009.04

Prothya Biosolutions Netherlands B.V.0 个研究点目标入组 4 人开始时间: 2024年7月15日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
入组人数
4

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
0 至 64(—)
性别
All

入选标准

  • Established diagnosis of atransferrinemia, defined as serum levels of transferrin below 40 mg/dL, Signed informed consent

排除标准

  • Known with allergic reactions against human plasma or plasma products, Having detectable anti-IgA antibodies, Fertile women unless they take valid contraceptive measures (ITA only)

研究者

相似试验

进行中(未招募)
1 期
Clinical trial to investigate the treatment with apotransferrin of patients with atransferrinemiaAtransferrinemiaMedDRA version: 20.0Level: LLTClassification code 10055212Term: Hypochromic microcytic anemiaSystem Organ Class: 100000004851MedDRA version: 20.0Level: LLTClassification code 10002272Term: AnemiaSystem Organ Class: 100000004851MedDRA version: 21.0Level: PTClassification code 10065973Term: Iron overloadSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 21.0Level: PTClassification code 10005620Term: Blood iron increasedSystem Organ Class: 10022891 - InvestigationsMedDRA version: 20.0Level: PTClassification code 10044356Term: Transferrin decreasedSystem Organ Class: 10022891 - Investigations
EUCTR2009-017409-13-DEProthya Biosolutions Netherlands B.V.6
招募中
2 期
Clinical trial to investigate the treatment with apotransferrin of patients with atransferrinemia
2024-515986-33-00Prothya Biosolutions Netherlands B.V.5
进行中(未招募)
不适用
Dose escalating study to evaluate pharmacokinetics, efficacy and safety of apotransferrin in atransferrinemia patients. Estudio de escalada de dosis para evaluar la farmacocinÊtica, la eficacia y la seguridad de apotransferrina, en pacientes con atransferrinemia. - Apotransferrin replacement in atransferrinemiaAtransferrinemiaMedDRA version: 12.1Level: LLTClassification code 10044357Term: Transferrin increasedMedDRA version: 12.1Level: LLTClassification code 10005620Term: Blood iron increasedMedDRA version: 12.1Level: LLTClassification code 10002272Term: Anemia
EUCTR2009-017409-13-ESSanquin Plasma Products
招募中
不适用
Dose escalation trial to evaluate the safety and the efficacy on new bone formation of a single local treatment with lithium carbonate to teeth extraction sockets for dental implant in Japanese participants
JPRN-UMIN000008795Kyushu University Hospital12
进行中(未招募)
不适用
A study in Rheumatoid Arthritis patients to look at two formulations of adalimumab for pharmacokinetics and safety.MedDRA version: 14.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid Arthritis
EUCTR2012-000535-36-CZAbbott GmbH & Co. KG100